title: Participation of liver progenitor cells in liver regeneration: lack of evidence in the AAF/PH rat model.
abstract: When hepatocyte proliferation is impaired, liver progenitor cells (LPC) are activated to participate in liver regeneration. We used the 2-acetaminofluorene/partial hepatectomy (AAF/PH) model to evaluate the contribution of LPC to liver cell replacement and function restoration. Fischer rats subjected to AAF/PH (or PH alone) were investigated 7, 10 and 14 days post-hepatectomy. Liver mass recovery (LMR) was estimated, and the liver mass to body weight ratio calculated. We used serum albumin and bilirubin levels, and liver albumin mRNA levels to assess the liver function. LPC expansion was analyzed by cytokeratin 19 (CK19), glutathione S-transferase protein (GSTp) immunohistochemistry and by CK19, CD133, transforming growth factor-β1 and hepatocyte growth factor mRNA expression in livers. Cell proliferation was evaluated by Ki67 and BrdU immunostaining. Compared with PH alone where LMR was ∼100% 14 days post-PH, LMR was defective in AAF/PH rats (64.1±15.5%, P=0.0004). LPC expansion was scarce in PH livers (0.5±0.4% of CK19(+) area), but significant in AAF/PH livers (8.5±7.2% of CK19(+)), and inversely correlated to LMR (r(2)=0.63, P<0.0001). A quarter of AAF/PH animals presented liver failure (low serum albumin and high serum bilirubin) 14 days post-PH. Compared with animals with preserved function, this was associated with a lower LMR (50±6.8 vs 74.6±9.4%, P=0.0005), a decreased liver to body weight ratio (2±0.3 vs 3.5±0.6%, P=0.001), and a larger LPC expansion such as proliferating Ki67(+) LPC covered 17.4±4.2% of the liver parenchyma vs 3.1±1.5%, (P<0.0001). Amongst those, rare LPC with an intermediate hepatocyte-like phenotype were seen. Also, less than 2% of hepatocytes were engaged into the cell cycle (Ki67(+)), while more numerous (∼25% of hepatocytes) in the livers with preserved function. These observations suggest that, in this model, the efficient recovery of the liver function was ensured rather by the proliferation of mature hepatocytes than by the LPC expansion and differentiation into hepatocytes.
authors.affiliation: Laboratory of Hepato-Gastroenterology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium.
authors.forename: Ange-Clarisse
authors.initials: AC
authors.lastname: Dusabineza
authors.forename: Noémi K
authors.initials: NK
authors.lastname: Van Hul
authors.forename: Jorge
authors.initials: J
authors.lastname: Abarca-Quinones
authors.forename: Peter
authors.initials: P
authors.lastname: Starkel
authors.forename: Mustapha
authors.initials: M
authors.lastname: Najimi
authors.forename: Isabelle A
authors.initials: IA
authors.lastname: Leclercq
mesh_terms: D015073:2-Acetylaminofluorene; D000071916:AC133 Antigen; D000818:Animals; D015703:Antigens, CD / Q000032:analysis; D006023:Glycoproteins / Q000032:analysis; D006498:Hepatectomy; D053539:Keratin-19 / Q000032:analysis; D008099:Liver / Q000166:cytology*; D008115:Liver Regeneration; D008297:Male; D023421:Models, Animal; D010455:Peptides / Q000032:analysis; D051381:Rats; D011916:Rats, Inbred F344; D013234:Stem Cells / Q000502:physiology*
chemical_list: D000071916:AC133 Antigen; D015703:Antigens, CD; D006023:Glycoproteins; D053539:Keratin-19; D010455:Peptides; C000606025:Prom1 protein, rat; D015073:2-Acetylaminofluorene